Skip to main content
Loading market data...
ETF NYSE Arca USD

State Street Health Care Select Sector SPDR ETF XLV

Issuer: State Street SEC registrant: SELECT SECTOR SPDR TRUST Equity · US
Last price 179.82 USD Change: Up +4.17 Percent change: Up +2.37%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.08%
Prospectus 31 Jan 2026
Net assets
$40.6B
As of 30 Jun 2026
Holdings
65
As of 30 Jun 2026
12-month distribution yield
1.42%
Quarterly
Asset class
Equity
From holdings

State Street Health Care Select Sector SPDR ETF (XLV) is an exchange-traded fund listed on NYSE Arca in the United States, issued by State Street. Its category is Equity · US (equity). Its last price was US$179.82 on 20 Oct 2026. Its expense ratio is 0.08% a year, from its prospectus dated 31 Jan 2026. It reported net assets of US$40.6 billion as of 30 Jun 2026. Its latest holdings report lists 65 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$2.55 a unit, a 12-month distribution yield of 1.42%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.08%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.03%
Prospectus date
31 Jan 2026
Filed with the SEC
28 Jan 2026

Size and reporting

Net assets
$40,598,944,976
Total assets
$40,609,814,997
Holdings as of
30 Jun 2026
Report made public
28 Aug 2026 (59 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 65 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.

XLV top holdings as of 30 Jun 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Eli Lilly & Co US5324571083 16.51% $6.7B Equity (common) United States USD
2 Johnson & Johnson US4781601046 10.64% $4.3B Equity (common) United States USD
3 AbbVie Inc US00287Y1091 7.74% $3.1B Equity (common) United States USD
4 UnitedHealth Group Inc US91324P1021 6.57% $2.7B Equity (common) United States USD
5 Merck & Co Inc US58933Y1055 5.52% $2.2B Equity (common) United States USD
6 Amgen Inc US0311621009 3.40% $1.4B Equity (common) United States USD
7 Thermo Fisher Scientific Inc US8835561023 3.24% $1.3B Equity (common) United States USD
8 Abbott Laboratories US0028241000 2.75% $1.1B Equity (common) United States USD
9 Gilead Sciences Inc US3755581036 2.73% $1.1B Equity (common) United States USD
10 Intuitive Surgical Inc US46120E6023 2.45% $995.0M Equity (common) United States USD
11 Pfizer Inc US7170811035 2.39% $969.6M Equity (common) United States USD
12 CVS Health Corp US1266501006 2.30% $932.5M Equity (common) United States USD
13 Vertex Pharmaceuticals Inc US92532F1003 2.19% $890.7M Equity (common) United States USD
14 Danaher Corp US2358511028 2.09% $847.7M Equity (common) United States USD
15 Bristol-Myers Squibb Co US1101221083 2.05% $831.3M Equity (common) United States USD
16 Stryker Corp US8636671013 1.89% $767.4M Equity (common) United States USD
17 Medtronic PLC IE00BTN1Y115 1.75% $709.6M Equity (common) Ireland USD
18 McKesson Corp US58155Q1031 1.58% $641.7M Equity (common) United States USD
19 Elevance Health Inc US0367521038 1.46% $593.3M Equity (common) United States USD
20 Cigna Group/The US1255231003 1.27% $515.2M Equity (common) United States USD
21 Boston Scientific Corp US1011371077 1.10% $448.2M Equity (common) United States USD
22 Regeneron Pharmaceuticals Inc US75886F1075 1.08% $440.2M Equity (common) United States USD
23 HCA Healthcare Inc US40412C1018 1.05% $427.7M Equity (common) United States USD
24 Cardinal Health Inc US14149Y1082 0.97% $393.1M Equity (common) United States USD
25 Cencora Inc US03073E1055 0.96% $388.9M Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 99.68%
Short-term investment vehicles (cash funds) 0.26%
Equity derivatives <0.01%

Country

Country by weight
CountryWeightBar
United States 97.85%
Ireland 2.11%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 99.95%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 87.53%
Industrials 7.29%
Consumer Staples 2.30%
Technology 0.46%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$2.5500
4 payments per unit
12-month yield
1.42%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
21 Sep 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($2.5500) ÷ latest price ($179.82) × 100 = 1.42%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (20 payments)
XLV distributions per unit by ex-date
Ex-dateAmount per unit
21 Sep 2026$0.6420
22 Jun 2026$0.6560
23 Mar 2026$0.5950
22 Dec 2025$0.6570
22 Sep 2025$0.6250
23 Jun 2025$0.6300
24 Mar 2025$0.5650
23 Dec 2024$0.6220
23 Sep 2024$0.5770
24 Jun 2024$0.5730
18 Mar 2024$0.5230
18 Dec 2023$0.5980
18 Sep 2023$0.5400
20 Jun 2023$0.5420
20 Mar 2023$0.4890
19 Dec 2022$0.5560
19 Sep 2022$0.5060
21 Jun 2022$0.5040
21 Mar 2022$0.4260
20 Dec 2021$0.5280

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme